NLRP3 Inflammasome Inhibitor I

製品コードS3680 バッチS368001

化学情報

	Synonyms	N/A	Storage (From the date of receipt)	3 years -20°C powder 1 years -80°C in solvent
	化学式	C₁₆H₁₇ClN₂O₄S
	分子量	368.84	CAS No.	16673-34-0
Solubility (25°C)*	体外	DMSO	73 mg/mL (197.91 mM)
		Water	Insoluble
		Ethanol	Insoluble
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	NLRP3 Inflammasome Inhibitor I, an intermediate substrate in the synthesis of glyburide which is free of the cyclohexylurea moiety involved in insulin release, is a novel inhibitor of the NLRP3 inflammasome.
in vitro	NLRP3 Inflammasome Inhibitor I inhibits the formation of the NLRP3 inflammasome in cardiomyocytes without affecting glucose metabolism.^[1]
in vivo	Treatment with 16673-34-0 in a model of acute myocardial infarction because of ischemia and reperfusion significantly inhibites the activity of inflammasome (caspase-1) in the heart by 90% (P < 0.01) and reduces infarct size, measured at pathology (by >40%, P < 0.01) and with troponin I levels (by >70%, P < 0.01).^[1]

プロトコル(参考用のみ)

細胞アッセイ	細胞株	J774A.1 cells, HL-1 cells
	濃度	400μM
	反応時間	30 min
	実験の流れ	Cells are cultured in a Claycomb medium and then primed with LPS (25 ng/mL) for 2 h and treated with ATP (5 mM) for 1 hour, to induce NLRP3 inflammasome formation. Cells are then treated with 16673-34-0 (400μM) or glyburide (400μM) during the LPS priming phase and then treated with ATP. The formation of the NLRP3 inflammasome is determined and quantified by ASC aggregation, caspase-1 activity, and cell death.
動物実験	動物モデル	Acute myocardial infarction (AMI) mouse model ( Adult male CD1 mice )
	投薬量	5mg/kg , 20 mg/kg , 100 mg/kg
	投与方法	i.p

参考

[1] Marchetti C, et al. J Cardiovasc Pharmacol. 2014 Apr;63(4):316-322.

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

股関節疾患の病態と治療に関する研究 [ eprints, 2023, 10.14943/doctoral.k15475]	PubMed: none
Inflammasome Activation in the Hip Synovium of Rapidly Destructive Coxopathy Patients and Its Relationship with the Development of Synovitis and Bone Loss [ Am J Pathol, 2022, S0002-9440(22)00076-1]	PubMed: 35292262
Mechanism of miR-126 in hypoxia-reoxygenation-induced cardiomyocyte pyroptosis by regulating HMGB1 and NLRP3 inflammasome [ Immunopharmacol Immunotoxicol, 2022, 1-24]	PubMed: 35297734
Emodin alleviates LPS-induced myocardial injury through inhibition of NLRP3 inflammasome activation [ Phytother Res, 2021, 10.1002/ptr.7191]	PubMed: 34131970
Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation [ Nutrients, 2021, 13(3)856]	PubMed: 33807927
Agmatine Alleviates Epileptic Seizures and Hippocampal Neuronal Damage by Inhibiting Gasdermin D-Mediated Pyroptosis [ Front Pharmacol, 2021, 12:627557]	PubMed: 34421582
Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. [ Drug Des Devel Ther, 2019, 13:975-990]	PubMed: 30988600
H2S alleviates renal injury and fibrosis in response to unilateral ureteral obstruction by regulating macrophage infiltration via inhibition of NLRP3 signaling. [ Exp Cell Res, 2019, 10.1016/j.yexcr.2019.111779]	PubMed: 31846625

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。